Literature DB >> 11966678

Beta-adrenoceptor blockers and serotonin.

Takeshi Terao.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11966678      PMCID: PMC1874260          DOI: 10.1046/j.1365-2125.2002.01572_4.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  Risk of suicide in users of beta-adrenoceptor blockers, calcium channel blockers and angiotensin converting enzyme inhibitors.

Authors:  H T Sørensen; L Mellemkjaer; J H Olsen
Journal:  Br J Clin Pharmacol       Date:  2001-09       Impact factor: 4.335

2.  Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment.

Authors:  V Pérez; I Gilaberte; D Faries; E Alvarez; F Artigas
Journal:  Lancet       Date:  1997-05-31       Impact factor: 79.321

3.  Mitchell B. Balter Award--1998. Pindolol and major affective disorders: a three-year follow-up study of 30,485 patients.

Authors:  P Räsänen; H Hakko; J Tiihonen
Journal:  J Clin Psychopharmacol       Date:  1999-08       Impact factor: 3.153

4.  How long should pindolol be associated with paroxetine to improve the antidepressant response?

Authors:  R Zanardi; F Artigas; L Franchini; L Sforzini; M Gasperini; E Smeraldi; J Perez
Journal:  J Clin Psychopharmacol       Date:  1997-12       Impact factor: 3.153

5.  Effect of pindolol on onset of action of paroxetine in the treatment of major depression: intermediate analysis of a double-blind, placebo-controlled trial. Réseau de Recherche et d'Expérimentation Psychopharmacologique.

Authors:  R Bordet; P Thomas; B Dupuis
Journal:  Am J Psychiatry       Date:  1998-10       Impact factor: 18.112

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.